About This Dosing Guide
This guide provides supplementary information for the Pancreaze Dosing Calculator. Pancreaze® (pancrelipase) is a prescription medicine used to treat people who cannot digest food normally because their pancreas does not make enough enzymes, a condition known as Exocrine Pancreatic Insufficiency (EPI). The dosing information presented here is based on the official prescribing information and is intended to help healthcare professionals understand the calculator's logic and outputs.
Understanding the Calculator's Outputs
The tool calculates a recommended dosing regimen based on your inputs. Here’s what each output value represents:
- Calculated Lipase per MEAL: The target dose of lipase units for a standard meal, based on weight or fat intake.
- Calculated Lipase per SNACK: The target dose for a snack, which is typically calculated as 50% of the meal dose.
- Total Calculated Lipase per DAY: An estimated total daily dose, assuming three meals and two snacks. This is compared against the maximum recommended daily limit.
- Recommended Regimen: The number of capsules of the selected Pancreaze formulation required to meet the calculated lipase dose for meals and snacks. Doses are rounded to the nearest whole capsule.
- Safety Note: A warning is displayed if the calculated dose exceeds the maximum recommended dose of 2,500 lipase units/kg/meal or 10,000 lipase units/kg/day.
How to Use the Calculator
Follow these steps to generate a sample dosing schedule:
- Select Patient Category: Choose the appropriate age group for the patient (Infant, Child >12 mo to <4 yr, or Child ≥ 4 yr & Adult).
- Enter Patient Weight: Input the patient's weight and select the unit (kg or lbs).
- Choose Dosing Method: Select "Weight-Based" for all patient categories or "Fat Intake-Based" for children ≥ 4 years and adults. If choosing the latter, enter the total grams of dietary fat consumed per day.
- Select Pancreaze Formulation: Choose the desired capsule strength from the dropdown menu.
- Calculate Dose: Click the "Calculate Dose" button to view the results. The regimen can be recalculated by changing any input.
Pancreaze Dosing Overview
Dosing for Pancreaze is individualized and should be titrated based on clinical response, symptoms, and stool fat analysis. The calculator uses the following starting points from the Prescribing Information:
- Infants (up to 12 months): 500 lipase units/kg of body weight per meal.
- Children (> 12 months to < 4 years): 1,000 lipase units/kg of body weight per meal.
- Children (≥ 4 years) and Adults: 500 lipase units/kg of body weight per meal.
For fat-based dosing in older children and adults, dosing is based on actual fat intake, typically initiated at a rate such as 800 lipase units/g of fat intake. The dose should be adjusted until a clinical response is achieved.
Switching Between Formulations
Patients can be switched between different strengths of Pancreaze capsules. When switching, ensure the total lipase dose per meal and snack remains consistent. Use the calculator to determine the equivalent number of capsules when changing to a higher or lower strength formulation to maintain the same therapeutic dose.
Managing a Missed Dose
If a dose is missed, the patient should take their next dose with their next meal or snack as scheduled. They should not take two doses at the same time to make up for a missed dose. Dosing should continue as prescribed.
Important Safety Alerts
The most significant risk associated with high doses of pancreatic enzyme products is fibrosing colonopathy, a rare but serious adverse reaction. The risk is higher in patients with cystic fibrosis. To mitigate this risk, doses should generally not exceed 2,500 lipase units/kg per meal or 10,000 lipase units/kg per day. Always titrate to the lowest effective dose.
Frequently Asked Questions (FAQ)
Why is the "Fat Intake-Based" dosing method restricted to certain age groups?
The Prescribing Information for Pancreaze outlines the fat intake-based dosing approach specifically for children aged 4 and older and for adults, as this method requires consistent tracking of dietary fat, which is more feasible in these populations.
How is the snack dose determined?
The standard clinical approach, reflected in the calculator, is to administer half of the full meal dose with snacks.
Can Pancreaze capsules be opened?
Yes, for patients who cannot swallow capsules whole, they can be opened and the contents sprinkled on a small amount of acidic soft food, such as applesauce. The mixture should be swallowed immediately without crushing or chewing. Do not mix directly into formula or breast milk.
Does the calculator account for variations in meal size or fat content?
No, the calculator provides a standardized starting regimen based on a typical meal structure. Doses must be adjusted by a healthcare professional based on the size and fat content of individual meals and the patient's clinical response.
What should I do if the calculated dose shows a warning?
A warning indicates the calculated dose exceeds the maximum recommendations. This requires careful clinical evaluation. High doses should be used with caution and only if clinically indicated, with close patient monitoring.
Why are there multiple strengths of Pancreaze available?
The different formulations (e.g., 2,600, 4,200, 10,500 lipase units) provide flexibility for dose titration, allowing clinicians to tailor the regimen to meet each patient's specific enzyme requirements precisely.
Is this calculator a substitute for the official Prescribing Information?
No. This tool is for educational and support purposes only. It is not a substitute for clinical judgment and the official, most current FDA-approved Prescribing Information must always be consulted for complete guidance.
References
- Pancreaze® (pancrelipase) Prescribing Information. VIVUS LLC. Access data from the FDA label database. View PDF
- Somarathna, T., & Thosani, N. C. (2021). Pancreatic Enzyme Replacement Therapy for Exocrine Pancreatic Insufficiency: A Review. Clinical and experimental gastroenterology, 14, 149–159. Read on PubMed
- Struyvenberg, M. R., Martin, C. R., & Freedman, S. D. (2017). Practical guide to exocrine pancreatic insufficiency - Breaking the myths. BMC medicine, 15(1), 29. Read on PubMed
- Cystic Fibrosis Foundation. Pancreatic Enzymes (PERT). Visit Website
